SCHEMBL14440633

SCHEMBL14440633

CCCCOC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@@H](F)[C@H](OCCCC)[C@@H](OCCCC)[C@@H]1OCCCC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EHMT1 Q9H9B1 1/20 0.52
▸ AHCY P23526 1/20 0.50
▸ NT5E P21589 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.47
▸ PDE2A O00408 1/20 0.46
▸ ADORA1 P30542 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ DPP4 P27487 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ SLC28A1 O00337 1/20 0.45
▸ MAP3K7 O43318 1/20 0.45
▸ SLC28A2 O43868 1/20 0.45
▸ GAPDH P04406 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ ADORA2A P29274 1/20 0.45
▸ ADORA2B P29275 1/20 0.45
▸ STAT6 P42226 1/20 0.45
▸ PI4KA P42356 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8970121 0.94 EHMT1 (0.56) EHMT1AHCYNT5EGAARXFP1
SCHEMBL14440221 0.89 EHMT1 (0.62) EHMT1AHCYRXFP1ADORA1SMN1; SMN2
SCHEMBL14440224 0.89 EHMT1 (0.62) EHMT1AHCYRXFP1ADORA1SMN1; SMN2
SCHEMBL11489328 0.89 EHMT1 (0.58) EHMT1AHCYGAARXFP1ADORA1
SCHEMBL8970443 0.84 EHMT1 (0.63) EHMT1AHCYNT5ERXFP1ADORA1
SCHEMBL10590849 0.84 EHMT1 (0.66) EHMT1AHCYRXFP1ADORA1SMN1; SMN2
SCHEMBL8971323 0.83 EHMT1 (0.59) EHMT1AHCYGAAADORA1SMN1; SMN2
SCHEMBL8671033 0.82 EHMT1 (0.74) EHMT1AHCYRXFP1ADORA1SMN1; SMN2
SCHEMBL8671037 0.82 EHMT1 (0.74) EHMT1AHCYRXFP1ADORA1SMN1; SMN2
SCHEMBL29936475 0.82 EHMT1 (0.74) EHMT1AHCYRXFP1ADORA1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185063-A1 Seven-membered ring nucleosides IDENIX PHARMACEUTICALS, INC. 2007-08-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185063-A1 Seven-membered ring nucleosides NSUN2, NSUN3, HAVCR2 EHMT1 2870/4885AHCY 531/4885NT5E 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback